75 related articles for article (PubMed ID: 7501573)
1. New oral agents for type II diabetes. Taking a more aggressive approach to therapy.
Hollander PA
Postgrad Med; 1995 Dec; 98(6):110-1, 115-6, 119-21, passim. PubMed ID: 7501573
[TBL] [Abstract][Full Text] [Related]
2. When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus.
Langer O
J Matern Fetal Neonatal Med; 2002 Apr; 11(4):218-25. PubMed ID: 12375674
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
Fisman EZ; Tenenbaum A; Motro M; Adler Y
Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
[TBL] [Abstract][Full Text] [Related]
4. [Update on new oral treatment for diabetes].
Awad J; Schindel B; Schindel Y
Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
[No Abstract] [Full Text] [Related]
5. [Approach to diabetic therapy. 2. Selection and the use of oral antidiabetics. 3) Biguanides and alpha-glucosidase inhibitors].
Onuma T
Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1536-43. PubMed ID: 11062901
[No Abstract] [Full Text] [Related]
6. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
[No Abstract] [Full Text] [Related]
7. [Effectiveness of oral hypoglycemic drugs in the metabolic control of patients with gestational diabetes].
Valdés R E; Soto-Chacón E; Lahsen M R; Barrera H C; Candía P P
Rev Med Chil; 2008 Jul; 136(7):915-20. PubMed ID: 18949170
[TBL] [Abstract][Full Text] [Related]
8. [Oral and dietary treatments of type 2 diabetes].
Godeau T; Charbonnel B
Rev Prat; 1992 May; 42(9):1093-8. PubMed ID: 1496236
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
Sieradzki J; Soszyński P
Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
[TBL] [Abstract][Full Text] [Related]
10. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
[TBL] [Abstract][Full Text] [Related]
11. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
Pernet A; Bäbler M; Ganz K
Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
[No Abstract] [Full Text] [Related]
12. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
13. [Drug therapy of type-II diabetes: tablets, insulin or a combination of these].
Diem P
Schweiz Rundsch Med Prax; 1994 Jan; 83(3):68-71. PubMed ID: 8296132
[TBL] [Abstract][Full Text] [Related]
14. New oral agents for type II diabetes.
Hollander PA
Postgrad Med; 1995 Dec; 98(6):110-126. PubMed ID: 29224437
[TBL] [Abstract][Full Text] [Related]
15. [Pitfalls in treatment with oral antidiabetic agents].
Perusicová J
Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.
Uwaifo GI; Ratner RE
Am J Cardiol; 2007 Feb; 99(4A):51B-67B. PubMed ID: 17307058
[TBL] [Abstract][Full Text] [Related]
17. Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes.
Tildesley HD; Aydin CM; Ignaszewski A; Strelzow JA; Yu E; Bondy G
Int J Cardiol; 2007 Feb; 115(3):312-7. PubMed ID: 16824633
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacologic treatment of diabetes].
De Montigny P; Clerc C; Descarpentries C
Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
[No Abstract] [Full Text] [Related]
19. [Combination therapy of oral hypoglycemic agents which enhance the efficacy of insulin therapy].
Hirose T
Nihon Rinsho; 2012 May; 70 Suppl 3():669-77. PubMed ID: 22768596
[No Abstract] [Full Text] [Related]
20. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
